processing....
Abdominal aortic aneurysms (AAAs) are relatively common and are potentially life-threatening. Aneurysms are defined as a focal dilatation comprising all three layers of an artery, with at least a 50% increase over the vessel’s normal diameter. Thus, enlargement of the diameter of the abdominal aorta to 3 cm or more satisfies this definition.
AAA usually results from degeneration in the media of the arterial wall, leading to a slow and continuous dilatation of the lumen of the vessel (see Pathophysiology). Uncommon causes include infection, cystic medial necrosis, arteritis, trauma, inherited connective-tissue disorders, and anastomotic disruption. (See Etiology.)
AAAs generally affect elderly White men (seeEpidemiology). Age is the most significant risk factor for development of AAA, and smoking appears to be the modifiable risk factor most strongly associated with AAA. In addition to increasing age and male sex, other risk factors include increased height, weight, body mass index (BMI), body surface area (BSA), peripheral vascular disease (PVD), hypertension, coronary artery disease, and cerebrovascular disease. A familiar clustering has been noted in 15-25% of patients undergoing surgical repair of AAA. Female sex, Black race, and the presence of diabetes mellitus are negatively associated with AAA. [1,2,3]
AAAs are usually asymptomatic and found incidentally until they expand or rupture. An expanding AAA causes sudden, severe, and constant low back, flank, abdominal, or groin pain. A pulsating sensation in the abdomen is sometimes reported. Syncope may be the chief complaint, with pain less prominent. In many cases, an AAA is detected as an incidental finding on diagnostic imaging obtained for other reasons. There is a wide spectrum of clinical presentations, and AAA should be considered in the differential diagnosis for a number of vague symptoms.
Most clinically significant AAAs are palpable upon routine physical examination. The presence of a pulsatile abdominal mass is virtually diagnostic but is found in fewer than half of all cases. A more concerning examination finding would be pain upon direct palpation over the AAA.
Patients with a ruptured AAA may present in frank shock due to bleeding, as evidenced by cyanosis, mottling, altered mental status, tachycardia, and hypotension. Abrupt onset of pain due to rupture of an AAA may be quite dramatic, with subtle associated physical findings. In some instances, however, patients may have normal vital signs in the presence of a ruptured AAA as a consequence of retroperitoneal containment of hematoma; therefore clinical suspicion must be high to evaluate for AAA.
At least 65% of patients with a ruptured AAA die of sudden cardiovascular collapse before arriving at a hospital. However, with current protocols for diagnostic screening for AAA and the growth of endovascular repair, in-hospital mortality after a ruptured AAA is in the range of 35-45%. [4]
SeePresentation for more detail.
No specific laboratory studies can be used to diagnose AAA. The following imaging studies can, however, be employed diagnostically:
SeeWorkup for more detail.
AAAs are usually reated with surgical repair in ruptured, symptomatic or appropriate sized aneurysms. [6,7,8]When indicated, unruptured aneurysms can undergo elective repair. The combination of US screening, medical management to reduce preoperative risk, and newer minimally invasive techniques extend aortic aneurysm treatment into an increasingly elderly population. If an AAA ruptures, emergency surgical repair is required. The primary repair methods are as follows:
SeeTreatment andMedication for more detail.
The abdominal aorta has three distinct tissue layers: intima, media, and adventitia. The intima is composed of the classic endothelial layer. The media consists of smooth-muscle cells surrounded by elastin, collagen, and proteoglycans; to a great extent, this layer is responsible for the structural and elastic properties of the artery. The adventitia consists primarily of collagen but also contains a variety of cells (including fibroblasts and immunomodulatory cells), as well as adrenergic nerves.
The diameter of the aorta decreases from its thoracic portion to its abdominal and infrarenal portions. A normal aorta shows a reduction in medial elastin layers from the thoracic portion to the abdominal portion. Elastin content and collagen content are also reduced.
Most AAAs begin below the renal arteries and end above the iliac arteries. The size, shape, and extent of AAAs vary considerably. Likethoracic aortic aneurysms (TAAs), AAAs may be broadly described as either fusiform (circumferential) or saccular (more localized). However, these descriptions represent two points on a continuum, and lesions that fall between the two points exist.
The important surgical and endovascular anatomic considerations include associated renal and visceral artery involvement (either in occlusive disease or involved in the aneurysm process) and the iliac artery (occlusive disease or aneurysm). The length of the infrarenal aortic neck is important in helping determine the surgical approach (ie, open or endovascular) and the location of the aortic cross-clamp.
Consideration of hypogastric artery (internal iliac) outflow is important in planning surgical repair. Loss of blood flow from the hypogastric artery may result in buttock claudication, impotence in males and sigmoid colon ischemia with necrosis.
Finally, inflammatory aneurysms represent a subsegment of AAAs and are characterized by a thick inflammatory peel. These aneurysms are associated with retroperitoneal fibrosis and adhesion of the duodenum (see the image below).
AAAs arise as a result of a destruction of the major structural proteins of the aorta (elastin and collagen). The inciting factors are not known, but a genetic predisposition clearly exists. Although aneurysms involve a dilatation in all three layers of the vessel wall, AAAs develop after degeneration of the media. The degeneration ultimately may lead to widening of the vessel lumen and loss of structural integrity.
After age 50 years, the normal diameter of the infrarenal aorta is 1.5 cm in women and 1.7 cm in men. An infrarenal aorta that is 3 cm or more in diameter is considered an AAA, even if asymptomatic. Approximately 90% of AAAs are infrarenal, and 30% of all aortic aneurysms occur in the infrarenal portion.
A multidisciplinary research program supported by the US National Heart, Lung, and Blood Institute identified the following as mechanisms important in the development of AAA [9]:
Similarly, surgical specimens of AAA have revealed the following (see the image below):
Elastin is the principal load-bearing element in the aorta. The aortic wall contains smooth muscle, elastin, and collagen arranged in concentric layers in order to withstand arterial pressure. The number of medial elastin layers is markedly reduced from the proximal thoracic aorta to the infrarenal aorta, with medial thinning and intimal thickening.
Elastin fragmentation and degeneration are observed in aneurysm walls. The decrease in content coupled with the histologic changes of this matrix protein in aneurysms may explain the propensity for aneurysm formation in the infrarenal aorta.
In AAA, the aortic media appears to degrade by way of a proteolytic process. This implies an increase in the concentration of proteolytic enzymes relative to the concentration of their inhibitors in the abdominal aorta as the individual ages.
Some research has focused on the role of the metalloproteinases, a group of zinc-dependent enzymes responsible for tissue remodeling. Reports have documented increased expression and activity of matrix metalloproteinases (MMPs) in people with AAAs. MMPs and other proteases have been shown to be secreted into the extracellular matrix of AAAs by macrophages and aortic smooth-muscle cells.
MMPs and their inhibitors are present in normal aortic tissue and are responsible for vessel-wall remodeling. Aneurysmal tissue tends to demonstrate increased MMP activity and decreased inhibitor activity, which favor the degradation of elastin and collagen. The mechanism that tips the balance in favor of degradation of elastin and collagen in the aortic wall of AAAs by MMPs and other proteases is not yet known.
Upon histologic examination, AAAs demonstrate a chronic adventitial and medial inflammatory infiltrate. Infiltration of AAAs with lymphocytes and macrophages may trigger protease activation via various cytokines (eg, interleukin [IL]-1, IL-6, IL-8, and tumor necrosis factor [TNF]-α).
Immunoreactive proteins are found more conspicuously in the abdominal aorta, and this may contribute to the increased frequency of aneurysms in this region. Studies have defined a matrix protein that is immunoreactive with immunoglobulin G in the aneurysm wall. This autoantigen appears to be a collagen-associated microfibril. Certain infectious agents (eg,Chlamydia pneumoniae andTreponema pallidum) have been associated with the development of this protein; however, no direct cause-and-effect relation has been demonstrated.
Through gene microarray analysis, various genes involved in extracellular matrix degradation, inflammation, and other processes observed in AAA formation have been shown to be upregulated, whereas others that may serve to prevent this occurrence are downregulated. The combination of proteolytic degradation of aortic-wall connective tissue, inflammation and immune responses, biomechanical wall stress, and molecular genetics represents a dynamic process that leads to aneurysmal deterioration of aortic tissue.
Most AAAs occur in individuals with advanced atherosclerosis. Atherosclerosis may induce AAA formation by causing mechanical weakening of the aortic wall with loss of elastic recoil, along with degenerative ischemic changes, through obstruction of the vasa vasorum.
Many patients with advanced atherosclerosis do not develop AAA, and some patients with no evidence of atherosclerosis do. The observed association between atherosclerosis and AAA probably is not causative; however, atherosclerosis may represent a nonspecific secondary response to vessel-wall injury that is induced by multiple factors.
AAA is thought to be a degenerative process of the aorta, the cause of which remains unclear. It is often attributed to atherosclerosis because these changes are observed in the aneurysm at the time of surgery. However, a study by Blanchard et al found that the risk factors for AAA differ from those for atherosclerosis, with no association between cholesterol and AAA. [1]In addition, atherosclerosis fails to explain the development of occlusion, which is observed in the disease process.
Patients at greatest risk for AAA are men who are older than 65 years and have peripheral atherosclerotic vascular disease. A history of smoking often is elicited. Accordingly, in 2005, the United States Preventive Services Task Force (USPSTF) recommended screening with US in men aged 65-75 years who had ever smoked. [10]These recommendations were subsequently updated [11]on the basis of evidence from a 2014 study by Guirguis-Blake et al. [12]
Subsequently, the Society for Vascular Surgery (SVS) recommended screening for AAA not only according to the previous USPSTF guidelines but also in patients with first-degree relatives with history of AAA and in healthy men or women older than 75 years with a history of smoking. [7,3]
A Swedish study showed that instances of AAA in elderly men have been decreasing, a phenomenon that can be attributed to a nationwide decline in smoking for the past 30 years, as well as the significantly improved longevity of the elderly population. [13]A one-time US scan is recommended for men once they reach age 65 years to detect and prevent possible occurrences of AAA.
Other risk factors for AAA include the following:
Less frequent causes of AAA includeMarfan syndrome,Ehlers-Danlos syndrome, and other collagen-vascular diseases. In fewer than 5% of cases, AAA is caused by a mycotic aneurysm of hematogenous origin. In these cases, local invasion of the intima and media gives rise to abscess formation and aneurysmal dilation of the vessel. Gram-positive organisms most commonly cause mycotic aneurysms. Other uncommon causes include cystic medial necrosis, arteritis, trauma, and anastomotic disruption producing pseudoaneurysms.
Persons who have first-degree relatives with AAA are at increased risk for AAA. The familial prevalence rate of AAA has been estimated at 15-25%. Studies by Majumder et al suggested that the genetic predisposition is isolated to a single dominant gene with low penetrance that increases with age. [14]
Tilson et al described the potential for an autoimmune basis for the development of AAA involving theDRB1 major histocompatibility locus. [15]This locus has been identified as a basis for inflammatory AAA.
In late 2018, the FDA issued a warning that fluoroquinolone use can increase the risk of aortic aneurysm and urged healthcare providers to avoid prescribing these antibiotics to patients with or at risk for an aortic aneurysm, such as those with peripheral atherosclerotic vascular disease, hypertension, or certain genetic conditions (eg, Marfan syndrome and Ehlers-Danlos syndrome), as well as the elderly. [16]
Aneurysm diameter is an important risk factor for rupture. In general, AAAs gradually enlarge (0.2-0.8 mm/y) and eventually rupture. Hemodynamic factors play an important role. Areas of high stress have been found in AAAs and appear to correlate with the site of rupture. Computer-generated geometric models have demonstrated that aneurysm volume is a better predictor of areas of peak wall stress than aneurysm diameter. This may have implications for determining which AAAs require surgical repair.
AAA rupture is believed to occur when the mechanical stress acting on the wall exceeds the strength of the wall tissue. Wall tension can be calculated by applying Laplace’s law, as follows:
P × R/W
where P is the mean arterial pressure (MAP), R is the radius of the vessel, and W is the thickness of the vessel wall. AAA-wall tension is a significant predictor of pending rupture. The actual tension in the AAA wall appears to be a more sensitive predictor of rupture than aneurysm diameter alone. For these reasons, the clinician may wish to achieve acute blood pressure control in patients with AAA and elevated blood pressure.
In autopsy studies, the frequency rate of AAA has ranged from 0.5% to 3.2%. In a large US Veterans Affairs screening study, the prevalence was 1.4%. [2]The likelihood of development has ranged from 3 to 117 cases per 100,000 person-years.
Ruptured AAA is the 13th-leading cause of death in the United States, causing an estimated 15,000 deaths per year. The frequency of rupture has been reproted to be 4.4 cases per 100,000 persons. The reported incidence of rupture has ranged from 1 to 21 cases per 100,000 person-years. Despite increased survival following diagnosis, incidence and crude mortality and morbidity seem to be increasing.
The frequency of asymptomatic AAA has been reported to be 8.2% in the United Kingdom, 8.8% in Italy, 4.2% in Denmark, and 8.5% in Sweden (in males only). The reported frequency of AAA in females has been much lower, 0.6-1.4%. The frequency of AAA rupture has been reported to be 6.9 cases per 100,000 persons in Sweden, 4.8 cases per 100,000 in Finland, and 13 cases per 100,000 in the United Kingdom.
The incidence of AAA begins to increase sharply after 50 years of age and peaks in the eighth decade of life (see the image below). In women, the onset of this increase is delayed and appears to occur at approximately age 60 years.
The male-to-female incidence ratio in people younger than 80 years is 2:1. In those older than 80 years, the ratio is 1:1. After menopause, women may experience faster AAA growth (particularly of fusiform aneurysms) and at smaller sizes than men do; this suggests that it might be advisable to carry out surveillance in postmenopausal women at shorter intervals than those specified in SVS guidelines. [17]
White men have the highest incidence of AAA (~3.5 times that in Black men). AAAs are uncommon in African Americans, Asians, and persons of Hispanic heritage.
For patients who suffer rupture of an AAA before hospital arrival, the prognosis is guarded. More than 50% do not survive to reach the emergency department (ED); for those who do, the survival rate drops by about 1% per minute. However, in the subset of patients who are not in severe shock and who receive expert surgical intervention in a timely manner, the survival rate is more favorable.
In 1988, 40,000 surgical reconstructions for AAA were performed in the United States, and substantial mortality differences between elective and emergency operations were noted. Because the mortality associated with elective aneurysm repair is drastically lower than that associated with repair of a ruptured AAA, the emphasis must be on early detection and repair free from complications.
In 2014, Ambler et al, in association with the Audit and Quality Improvement Committee of the Vascular Society of Great Britain and Ireland, used data collected during a 15-month period in the United Kingdom National Vascular Database to develop a model for assessing the risk of in-hospital mortality after AAA repair. [18]
A retrospective study by Leyba et al (N = 22,395; 16,125 male, 6270 female; 18,655 White, 1555 Black, 1095 Hispanic, 470 Asian or Pacific Islander, 80 Native American) examined sex- and race-related disparities in inpatient outcomes for patients with ruptured AAAs in the United States. [19] Compared with male patients, female patients were less likely to undergo EVAR and more likely to die while hospitalized. Despite having a higher rate of comorbidity, Black patients were less like to die during hospitalization than White patients.
The long-term prognosis is related to associated comorbidities. Long-term survival is shortened by chronicheart failure and COPD. Rupture of associated TAAs is also an important cause of late death. Overall, AAA repair is very durable, with few long-term complications (< 5% false aneurysm). In general, the survival rate of patients with successful AAA repair is comparable to that of people in the age-matched population at large who have never had an aneurysm. [20,21]
Blanchard JF, Armenian HK, Friesen PP. Risk factors for abdominal aortic aneurysm: results of a case-control study.Am J Epidemiol. 2000 Mar 15. 151 (6):575-83.[QxMD MEDLINE Link].
Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group.Ann Intern Med. 1997 Mar 15. 126 (6):441-9.[QxMD MEDLINE Link].
Roy RA, Pruitt EY, Upchurch GR. Aortoiliac aneurysms: evaluation, decision making, and medical management. Sidawy AN, Perler BA, eds.Rutherford's Vascular Surgery and Endovascular Therapy. 10th ed. Philadelphia: Elsevier; 2023. 914-24.
Salata K, Lindsay T. Ruptured aortoiliac aneurysms and their management. Sidawy AN, Perler BA, eds.Rutherford's Vascular Surgery and Endovascular Therapy. 10th ed. Philadelphia: Elsevier; 2023. 976-94.
[Guideline] Expert Panel on Vascular Imaging, Lee YJ, Aghayev A, Azene EM, Bhatti S, Ewell JC, et al. ACR Appropriateness Criteria® Screening for Abdominal Aortic Aneurysm.J Am Coll Radiol. 2024 Jun. 21 (6S):S286-S291.[QxMD MEDLINE Link].[Full Text].
Gloviczki P, Lawrence PF, Forbes TL. Update of the Society for Vascular Surgery abdominal aortic aneurysm guidelines.J Vasc Surg. 2018 Jan. 67 (1):1.[QxMD MEDLINE Link].[Full Text].
[Guideline] Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA, Mansour MA, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm.J Vasc Surg. 2018 Jan. 67 (1):2-77.e2.[QxMD MEDLINE Link].[Full Text].
[Guideline] Wanhainen A, Van Herzeele I, Bastos Goncalves F, Bellmunt Montoya S, Berard X, Boyle JR, et al. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms.Eur J Vasc Endovasc Surg. 2024 Feb. 67 (2):192-331.[QxMD MEDLINE Link].[Full Text].
Wassef M, Baxter BT, Chisholm RL, Dalman RL, Fillinger MF, Heinecke J, et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute.J Vasc Surg. 2001 Oct. 34 (4):730-8.[QxMD MEDLINE Link].
[Guideline] U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement.Ann Intern Med. 2005 Feb 1. 142 (3):198-202.[QxMD MEDLINE Link].[Full Text].
[Guideline] LeFevre ML, U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2014 Aug 19. 161 (4):281-90.[QxMD MEDLINE Link].[Full Text].
Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP. Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force.Ann Intern Med. 2014 Mar 4. 160 (5):321-9.[QxMD MEDLINE Link].
Svensjö S, Björck M, Gürtelschmid M, Djavani Gidlund K, Hellberg A, Wanhainen A. Low prevalence of abdominal aortic aneurysm among 65-year-old Swedish men indicates a change in the epidemiology of the disease.Circulation. 2011 Sep 6. 124 (10):1118-23.[QxMD MEDLINE Link].
Majumder PP, St Jean PL, Ferrell RE, Webster MW, Steed DL. On the inheritance of abdominal aortic aneurysm.Am J Hum Genet. 1991 Jan. 48 (1):164-70.[QxMD MEDLINE Link].[Full Text].
Tilson MD, Ozsvath KJ, Hirose H, Xia S. A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm resides in the MHC class II locus DR-beta-1.Ann N Y Acad Sci. 1996 Nov 18. 800:208-15.[QxMD MEDLINE Link].
FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. US Food and Drug Administration. Available athttps://www.fda.gov/Drugs/DrugSafety/ucm628753.htm. December 20, 2018; Accessed: September 30, 2024.
DiLosa K, Brittenham G, Pozolo C, Hedayati N, Kwong M, Maximus S, et al. Evaluating growth patterns of abdominal aortic aneurysms among women.J Vasc Surg. 2024 Jul. 80 (1):107-113.[QxMD MEDLINE Link].[Full Text].
Ambler GK, Gohel MS, Mitchell DC, Loftus IM, Boyle JR, Audit and Quality Improvement Committee of the Vascular Society of Great Britain and Ireland. The Abdominal Aortic Aneurysm Statistically Corrected Operative Risk Evaluation (AAA SCORE) for predicting mortality after open and endovascular interventions.J Vasc Surg. 2015 Jan. 61 (1):35-43.[QxMD MEDLINE Link].
Leyba K, Hanif H, Millhuff AC, Quazi MA, Sohail AH, Clark RM, et al. Racial and sex disparities in inpatient outcomes of patients with ruptured abdominal aortic aneurysms in the United States.J Vasc Surg. 2024 Jul. 80 (1):115-124.e5.[QxMD MEDLINE Link].
Von Allmen RS, Powell JT. The management of ruptured abdominal aortic aneurysms: screening for abdominal aortic aneurysm and incidence of rupture.J Cardiovasc Surg (Torino). 2012 Feb. 53 (1):69-76.[QxMD MEDLINE Link].
Anjum A, von Allmen R, Greenhalgh R, Powell JT. Explaining the decrease in mortality from abdominal aortic aneurysm rupture.Br J Surg. 2012 May. 99 (5):637-45.[QxMD MEDLINE Link].
Daly KJ, Torella F, Ashleigh R, McCollum CN. Screening, diagnosis and advances in aortic aneurysm surgery.Gerontology. 2004 Nov-Dec. 50 (6):349-59.[QxMD MEDLINE Link].
Blaivas M, Theodoro D. Frequency of incomplete abdominal aorta visualization by emergency department bedside ultrasound.Acad Emerg Med. 2004 Jan. 11 (1):103-5.[QxMD MEDLINE Link].
Bobadilla JL, Suwanabol PA, Reeder SB, Pozniak MA, Bley TA, Tefera G. Clinical implications of non-contrast-enhanced computed tomography for follow-up after endovascular abdominal aortic aneurysm repair.Ann Vasc Surg. 2013 Nov. 27 (8):1042-8.[QxMD MEDLINE Link].
Clarençon F, Di Maria F, Cormier E, Gaudric J, Sourour N, Gabrieli J, et al. Comparison of intra-aortic computed tomography angiography to conventional angiography in the presurgical visualization of the Adamkiewicz artery: first results in patients with thoracoabdominal aortic aneurysms.Neuroradiology. 2013 Nov. 55 (11):1379-87.[QxMD MEDLINE Link].
[Guideline] Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines.J Vasc Surg. 2009 Oct. 50 (4 Suppl):S2-49.[QxMD MEDLINE Link].[Full Text].
The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants.Lancet. 1998 Nov 21. 352 (9141):1649-55.[QxMD MEDLINE Link].
Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms.N Engl J Med. 2002 May 9. 346 (19):1437-44.[QxMD MEDLINE Link].
Fillinger MF, Raghavan ML, Marra SP, Cronenwett JL, Kennedy FE. In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk.J Vasc Surg. 2002 Sep. 36 (3):589-97.[QxMD MEDLINE Link].[Full Text].
Eliason JL, Upchurch GR Jr. Endovascular abdominal aortic aneurysm repair.Circulation. 2008 Apr 1. 117 (13):1738-44.[QxMD MEDLINE Link].[Full Text].
Santos-Venâncio M, Rocha-Neves J, Spath P, Oliveira-Pinto J. Complications and Technical Success on Upper Limb Vascular Access for Endovascular Repair of Complex Abdominal and Thoraco-abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.Ann Vasc Surg. 2024 Dec. 109:433-443.[QxMD MEDLINE Link].
United Kingdom EVAR Trial Investigators., Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D, et al. Endovascular versus open repair of abdominal aortic aneurysm.N Engl J Med. 2010 May 20. 362 (20):1863-71.[QxMD MEDLINE Link].
Patel R, Sweeting MJ, Powell JT, Greenhalgh RM, EVAR trial investigators. Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.Lancet. 2016 Nov 12. 388 (10058):2366-2374.[QxMD MEDLINE Link].
Filardo G, Lederle FA, Ballard DJ, Hamilton C, da Graca B, Herrin J, et al. Immediate open repair vs surveillance in patients with small abdominal aortic aneurysms: survival differences by aneurysm size.Mayo Clin Proc. 2013 Sep. 88 (9):910-9.[QxMD MEDLINE Link].
United Kingdom EVAR Trial Investigators., Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair.N Engl J Med. 2010 May 20. 362 (20):1872-80.[QxMD MEDLINE Link].
De Bruin JL, Baas AF, Buth J, Prinssen M, Verhoeven EL, Cuypers PW, et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm.N Engl J Med. 2010 May 20. 362 (20):1881-9.[QxMD MEDLINE Link].
O’Riordan M. EVAR improves aneurysm-related survival over surgery. Medscape Medical News. Available athttps://www.medscape.com/viewarticle/778123. January 24, 2013; Accessed: September 30, 2024.
Mehta M, Paty PS, Byrne J, Roddy SP, Taggert JB, Sternbach Y, et al. The impact of hemodynamic status on outcomes of endovascular abdominal aortic aneurysm repair for rupture.J Vasc Surg. 2013 May. 57 (5):1255-60.[QxMD MEDLINE Link].
Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT Jr, Matsumura JS, et al. Open versus Endovascular Repair of Abdominal Aortic Aneurysm.N Engl J Med. 2019 May 30. 380 (22):2126-2135.[QxMD MEDLINE Link].[Full Text].
Antoniou GA, Antoniou SA, Torella F. Editor's Choice - Endovascular vs. Open Repair for Abdominal Aortic Aneurysm: Systematic Review and Meta-analysis of Updated Peri-operative and Long Term Data of Randomised Controlled Trials.Eur J Vasc Endovasc Surg. 2020 Mar. 59 (3):385-397.[QxMD MEDLINE Link].[Full Text].
Le Manach Y, Collins GS, Ibanez C, Goarin JP, Coriat P, Gaudric J, et al. Impact of perioperative bleeding on the protective effect of β-blockers during infrarenal aortic reconstruction.Anesthesiology. 2012 Dec. 117 (6):1203-11.[QxMD MEDLINE Link].
Schanzer A, Greenberg RK, Hevelone N, Robinson WP, Eslami MH, Goldberg RJ, et al. Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair.Circulation. 2011 Jun 21. 123 (24):2848-55.[QxMD MEDLINE Link].
Lederle FA, Freischlag JA, Kyriakides TC, Padberg FT Jr, Matsumura JS, Kohler TR, et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial.JAMA. 2009 Oct 14. 302 (14):1535-42.[QxMD MEDLINE Link].
Nishimori M, Low JH, Zheng H, Ballantyne JC. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.Cochrane Database Syst Rev. 2012 Jul 11. 7:CD005059.[QxMD MEDLINE Link].
Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms.Ann Vasc Surg. 1991 Nov. 5 (6):491-9.[QxMD MEDLINE Link].
Reichart M, Geelkerken RH, Huisman AB, van Det RJ, de Smit P, Volker EP. Ruptured abdominal aortic aneurysm: endovascular repair is feasible in 40% of patients.Eur J Vasc Endovasc Surg. 2003 Nov. 26 (5):479-86.[QxMD MEDLINE Link].
Conroy PD, Rastogi V, Yadavalli SD, Solomon Y, Romijn AS, Dansey K, et al. The rise of endovascular repair for abdominal, thoracoabdominal, and thoracic aortic aneurysms.J Vasc Surg. 2024 Jun 26.[QxMD MEDLINE Link].
Tan JW, Yeo KK, Laird JR. Food and Drug Administration-approved endovascular repair devices for abdominal aortic aneurysms: a review.J Vasc Interv Radiol. 2008 Jun. 19 (6 Suppl):S9-S17.[QxMD MEDLINE Link].
White GH, Yu W, May J. Endoleak--a proposed new terminology to describe incomplete aneurysm exclusion by an endoluminal graft.J Endovasc Surg. 1996 Feb. 3 (1):124-5.[QxMD MEDLINE Link].
Blecha M, Scali S, Stone D, Mao J, Goodney P, Lemmon G. Duplex Ultrasound-Only Surveillance after Endovascular Abdominal Aortic Aneurysm Repair is Associated with Favorable Long-Term Outcomes.Ann Vasc Surg. 2024 Jun 26. 108:112-126.[QxMD MEDLINE Link].
Lowest Risk | Moderate Risk | High Risk |
Age < 70 y | Age 70-80 y | Age 80 y |
Physically active | Active | Inactive, poor stamina |
No clinically overt cardiac disease | Stable coronary disease; remote MI; LVEF >35% | Significant coronary disease; recent MI; frequent angina; CHF; LVEF < 25% |
No significant comorbidities | Mild COPD | Limiting COPD; dyspnea at rest; O2 dependency; FEV1< 1 L/sec |
... | Creatinine 2.0-3.0 mg/dL | ... |
Normal anatomy | Adverse anatomy or AAA characteristics | Creatinine >3 mg/dL |
No adverse AAA characteristics | ... | Liver disease (↑PT; albumin < 2 g/dL) |
Anticipated operative mortality, 1-3% | Anticipated operative mortality, 3-7% | Anticipated operative mortality, at least 5-10%; each comorbid condition adds ~3-5% mortality risk |
AAA = abdominal aortic aneurysm; CHF = chronic heart failure; COPD = chronic obstructive pulmonary disease; FEV1 = forced expiratory volume in 1 second; LVEF = left ventricular ejection fraction; MI = myocardial infarction; PT = prothrombin time. |
AAA Diameter (cm) | Rupture Risk (%/y) |
< 4 | 0 |
4-5 | 0.5-5 |
5-6 | 3-15 |
6-7 | 10-20 |
7-8 | 20-40 |
>8 | 30-50 |
AAA = abdominal aortic aneurysm. |
Factor | Low Risk | Average Risk | High Risk |
Diameter | < 5 cm | 5-6 cm | >6 cm |
Expansion | < 0.3 cm/y | 0.3-0.6 cm/y | >0.6 cm/y |
Smoking/COPD | None, mild | Moderate | Severe/steroids |
Family history | No relatives | One relative | Numerous relatives |
Hypertension | Normal blood pressure | Controlled | Poorly controlled |
Shape | Fusiform | Saccular | Very eccentric |
Wall stress | Low (35 N/cm2 | Medium (40 N/cm2 | High (45 N/cm2) |
Sex | ... | Male | Female |
COPD = chronic obstructive pulmonary disease. |
Huong Khanh Truong, MD, RPVI Assistant Professor, Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Rutgers Robert Wood Johnson University Hospital
Huong Khanh Truong, MD, RPVI is a member of the following medical societies:Eastern Vascular Society
Disclosure: Nothing to disclose.
Vincent Lopez Rowe, MD, FACS Professor and Chief, Division of Vascular and Endovascular Surgery, Gonda (Goldschmied) Vascular Center, University of California, Los Angeles, David Geffen School of Medicine
Vincent Lopez Rowe, MD, FACS is a member of the following medical societies:American College of Surgeons,American Heart Association,American Surgical Association,Society for Clinical Vascular Surgery,Society for Vascular Surgery,Society of Black Academic Surgeons,Society of Black Vascular Surgeons,Southern California Vascular Surgical Society,Western Vascular Society
Disclosure: Nothing to disclose.
Saum A Rahimi, MD, FACS Interim Chief, Assistant Professor of Surgery, Division of Vascular Surgery, Rutgers Robert Wood Johnson Medical School
Saum A Rahimi, MD, FACS is a member of the following medical societies:American College of Surgeons,Society for Vascular Surgery,Eastern Vascular Society, Vascular Society of New Jersey
Disclosure: Nothing to disclose.
Suman Annambhotla, MD Fellow in Vascular Surgery, Northwestern University, The Feinberg School of Medicine
Suman Annambhotla, MD is a member of the following medical societies:American College of Surgeons,American Medical Association,Association for Academic Surgery, andSociety for Vascular Surgery
Disclosure: Nothing to disclose.
Edward Bessman, MD, MBA Chairman and Clinical Director, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University School of Medicine
Edward Bessman, MD, MBA is a member of the following medical societies:American Academy of Emergency Medicine,American College of Emergency Physicians, andSociety for Academic Emergency Medicine
Disclosure: Nothing to disclose.
David FM Brown, MD Associate Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies:American College of Emergency Physicians andSociety for Academic Emergency Medicine
Disclosure: lippincott Royalty textbook royalty; wiley Royalty textbook royalty
Jeffrey Lawrence Kaufman, MD Associate Professor, Department of Surgery, Division of Vascular Surgery, Tufts University School of Medicine
Jeffrey Lawrence Kaufman, MD is a member of the following medical societies:Alpha Omega Alpha,American College of Surgeons,American Society for Artificial Internal Organs,Association for Academic Surgery,Association for Surgical Education,Massachusetts Medical Society,Phi Beta Kappa, andSociety for Vascular Surgery
Disclosure: Nothing to disclose.
Robert E O'Connor, MD, MPH Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies:American Academy of Emergency Medicine,American College of Emergency Physicians,American College of Physician Executives,American Heart Association,American Medical Association,Medical Society of Delaware,National Association of EMS Physicians,Society for Academic Emergency Medicine, andWilderness Medical Society
Disclosure: Nothing to disclose.
William H Pearce, MD Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University, The Feinberg School of Medicine
William H Pearce, MD is a member of the following medical societies:American College of Surgeons,American Heart Association,American Surgical Association,Association for Academic Surgery,Association of VA Surgeons,Central Surgical Association,New York Academy of Sciences,Society for Vascular Surgery,Society of Critical Care Medicine,Society of University Surgeons, andWestern Surgical Association
Disclosure: Nothing to disclose.
Gary Setnik, MD Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School
Gary Setnik, MD is a member of the following medical societies:American College of Emergency Physicians,National Association of EMS Physicians, andSociety for Academic Emergency Medicine
Disclosure: SironaHealth Salary Management position; South Middlesex EMS Consortium Salary Management position; ProceduresConsult.com Royalty Other
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Medscape Salary Employment